Latin America and the Caribbean vs Mauritius: Proportion of the target population who received the final dose of
Latin America and the Caribbean
69.0%
in 2024
Mauritius
92.0%
in 2024
Latin America and the Caribbean rank
4th
Mauritius rank
6th
Proportion of the target population who received the final dose of over time
- Latin America and the Caribbean
- Mauritius
How they compare
Mauritius currently reports 92.0% against 69.0% in Latin America and the Caribbean, a difference of 23.0%.
That makes Mauritius's figure about 1.3 times Latin America and the Caribbean's.
The two have swapped places 2 times across 8 shared years of data; in 2017 it was Mauritius ahead.
Latin America and the Caribbean ranks 4th and Mauritius ranks 6th of 35 groups.
Mauritius has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Latin America and the Caribbean | Mauritius | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 58.7% | 77.3% | 18.7% | Mauritius |
| 2020s | 49.4% | 54.2% | 4.8% | Mauritius |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Latin America and the Caribbean or Mauritius?
- Mauritius, at 92.0% against 69.0% in Latin America and the Caribbean as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Latin America and the Caribbean and Mauritius?
- 23.0%, with Mauritius ahead.
- How many years of comparable data are there for Latin America and the Caribbean and Mauritius?
- 8 years are reported by both, from 2017 to 2024.
- How do Latin America and the Caribbean and Mauritius rank globally for proportion of the target population who received the final dose of?
- Latin America and the Caribbean ranks 4th and Mauritius ranks 6th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.